Erythrocytosis associated with IgA nephropathy
2
Issued Date
2022-01-01
Resource Type
eISSN
23523964
Scopus ID
2-s2.0-85121618361
Pubmed ID
34959131
Journal Title
eBioMedicine
Volume
75
Rights Holder(s)
SCOPUS
Bibliographic Citation
eBioMedicine Vol.75 (2022)
Suggested Citation
Cohen C., Coulon S., Bhukhai K., Neuraz A., Dussiot M., Fouquet G., Stang M.B.L., Flamant M., Vrtovsnik F., Hummel A., Knebelmann B., Mesnard L., Rondeau E., Maciel T.T., Favale F., Casadevall N., Nguyen-Khoa T., Moutereau S., Legendre C., Benhamou M., Monteiro R.C., Hermine O., El Karoui K., Moura I.C. Erythrocytosis associated with IgA nephropathy. eBioMedicine Vol.75 (2022). doi:10.1016/j.ebiom.2021.103785 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/83938
Title
Erythrocytosis associated with IgA nephropathy
Author's Affiliation
Other Contributor(s)
Abstract
Background: Erythrocytosis is a hematological disorder usually related to hematopoietic stem cell somatic mutations. However, unexplained erythrocytosis remains frequent. In this study, we evaluated the involvement of IgA1, a regulator of erythropoiesis also implicated in IgA nephropathy (IgAN) pathophysiology, in unexplained polycythemia/erythrocytosis (PE) of IgAN patients. Methods: IgAN-PE patients’ serum was collected, analyzed and used to study IgA1 effect on proliferation and differentiation of erythroid progenitors. Hematological parameters of transgenic mice for human alpha1 heavy chain were studied. Multicentric observational cohorts of chronic kidney disease (CKD) patients, including both native kidney diseases and renal transplants, were studied to analyze patient hemoglobin levels. Findings: We retrospectively identified 6 patients with IgAN and unexplained PE. In large CKD cohorts, IgAN was associated with PE in 3.5% of patients (p<0.001 compared to other nephropathies). IgAN was an independent factor associated with higher hemoglobin levels (13.1g/dL vs 12.2 g/dL, p=0.01). During post-transplant anemia, anemia recovery was faster in IgAN patients. Elevated polymeric/monomeric IgA1 ratio as well as high Gd-IgA1 rate were observed in circulating IgA1 of the 6 IgAN-PE patients as compared with control or IgAN patients without PE. IgA1 from these patients increased the sensitivity of erythroid progenitors to Epo. In mice, we also observed an elevation of hematocrit in alpha1 knock-in mice compared to wild type controls. Interpretation: These data identify a new etiology of erythrocytosis and demonstrate the role of pIgA1 in human erythropoiesis. This syndrome of IgA-related erythrocytosis should be investigated in case of unexplained erythrocytosis and renal disease. Funding: This work was supported by INSERM (French national institute for health and medical research), Labex GRex and Imagine Institute (Paris, France)